Apar Kishor Ganti, MD, discusses molecular targets to test for in lung cancer; treatment approaches for small cell lung cancer; and immunotherapy options for patients with metastatic non–small cell lung cancer in the frontline setting and beyond.
Between 2011 and 2020, cancer on average claimed just under 3,500 Nebraskans a year, roughly 50 more than died annually from heart disease, CDC data show.